FR2458546B1 - - Google Patents

Info

Publication number
FR2458546B1
FR2458546B1 FR7914562A FR7914562A FR2458546B1 FR 2458546 B1 FR2458546 B1 FR 2458546B1 FR 7914562 A FR7914562 A FR 7914562A FR 7914562 A FR7914562 A FR 7914562A FR 2458546 B1 FR2458546 B1 FR 2458546B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7914562A
Other languages
French (fr)
Other versions
FR2458546A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Francaise Hoechst Ste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francaise Hoechst Ste filed Critical Francaise Hoechst Ste
Priority to FR7914562A priority Critical patent/FR2458546A1/fr
Priority to GB8018699A priority patent/GB2053206B/en
Publication of FR2458546A1 publication Critical patent/FR2458546A1/fr
Application granted granted Critical
Publication of FR2458546B1 publication Critical patent/FR2458546B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7914562A 1979-06-07 1979-06-07 Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant Granted FR2458546A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7914562A FR2458546A1 (fr) 1979-06-07 1979-06-07 Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant
GB8018699A GB2053206B (en) 1979-06-07 1980-06-06 Process for manufacturing racemic 5-aryl hydantoins and products thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7914562A FR2458546A1 (fr) 1979-06-07 1979-06-07 Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Publications (2)

Publication Number Publication Date
FR2458546A1 FR2458546A1 (fr) 1981-01-02
FR2458546B1 true FR2458546B1 (ref) 1983-05-13

Family

ID=9226319

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7914562A Granted FR2458546A1 (fr) 1979-06-07 1979-06-07 Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Country Status (2)

Country Link
FR (1) FR2458546A1 (ref)
GB (1) GB2053206B (ref)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452806A (en) * 1982-11-01 1984-06-05 Pfizer Inc. Treating diabetic complications with 5-(substituted phenyl)hydantoins
US4457939A (en) * 1982-11-01 1984-07-03 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxy-3-substituted phenyl)hydantoins
DE3368614D1 (en) * 1982-11-01 1987-02-05 Pfizer 5-(substituted phenyl) hydantoins
AT398199B (de) * 1992-11-27 1994-10-25 Chemie Linz Gmbh Verfahren zur herstellung von arylhydantoinen
DE4301244A1 (de) * 1993-01-19 1994-07-21 Chemie Linz Deutschland Verfahren zur Herstellung von Arylhydantoinen
AU2003282920A1 (en) 2002-10-04 2004-05-04 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2891069A (en) * 1957-07-01 1959-06-16 Spencer Chem Co 5-(2, 4-dihalophenyl) hydantoins
FR1326693A (fr) * 1961-05-08 1963-05-10 Spencer Chem Co Nouvelles compositions contenant des herbicides et un agent antagoniste de ces derniers et méthode pour le traitement des graines à l'aide desdites compositions
CH587903A5 (ref) * 1973-05-07 1977-05-13 Ciba Geigy Ag

Also Published As

Publication number Publication date
GB2053206B (en) 1983-02-23
FR2458546A1 (fr) 1981-01-02
GB2053206A (en) 1981-02-04

Similar Documents

Publication Publication Date Title
FR2449707B1 (ref)
FR2447198B1 (ref)
BR8002583A (ref)
FR2445840B1 (ref)
FR2448573B1 (ref)
BR8006808A (ref)
CH624256B (ref)
FR2449187B1 (ref)
FR2450192B1 (ref)
FR2448992B3 (ref)
FR2447058B1 (ref)
FR2447761B1 (ref)
FR2450399B3 (ref)
AU78569S (ref)
AU78386S (ref)
AU79557S (ref)
AU78271S (ref)
AU79950S (ref)
AU79200S (ref)
AU80228S (ref)
AU77669S (ref)
BR5901094U (ref)
AU78391S (ref)
AU78385S (ref)
AU79826S (ref)

Legal Events

Date Code Title Description
ST Notification of lapse